Genetron Holdings Stock Beta
Genetron Holdings fundamentals help investors to digest information that contributes to Genetron Holdings' financial success or failures. It also enables traders to predict the movement of Genetron Stock. The fundamental analysis module provides a way to measure Genetron Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetron Holdings stock.
Genetron |
Genetron Holdings Company Beta Analysis
Genetron Holdings' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Genetron Holdings Beta | 0.5 |
Most of Genetron Holdings' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genetron Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Genetron Holdings has a Beta of 0.498. This is 42.09% lower than that of the Biotechnology sector and 65.42% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Genetron Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetron Holdings' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetron Holdings could also be used in its relative valuation, which is a method of valuing Genetron Holdings by comparing valuation metrics of similar companies.Genetron Holdings is currently under evaluation in beta category among its peers.
As returns on the market increase, Genetron Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Genetron Holdings is expected to be smaller as well.
Genetron Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (0.87) % | |||
| Current Valuation | 102.87 M | |||
| Shares Outstanding | 31.62 M | |||
| Shares Owned By Insiders | 6.82 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Number Of Shares Shorted | 20.78 K | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 650.71 M | |||
| Gross Profit | 337.97 M | |||
| EBITDA | (546.24 M) | |||
| Net Income | (810.63 M) | |||
| Cash And Equivalents | 472.68 M | |||
| Cash Per Share | 5.10 X | |||
| Total Debt | 158.57 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 2.83 X | |||
| Book Value Per Share | 17.90 X | |||
| Cash Flow From Operations | (460.2 M) | |||
| Short Ratio | 0.29 X | |||
| Earnings Per Share | (3.62) X | |||
| Target Price | 1.34 | |||
| Number Of Employees | 993 | |||
| Beta | 0.5 | |||
| Market Capitalization | 127.29 M | |||
| Total Asset | 975.33 M | |||
| Retained Earnings | (6.25 B) | |||
| Working Capital | 319.08 M | |||
| Z Score | -9.27 | |||
| Net Asset | 975.33 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |